Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : Formerly About Advanced Micro Devices -- Ignore unavailable to you. Want to Upgrade?

To: Broken_Clock who wrote (1341665)	2/8/2022 1:46:24 PM
From: Tenchusatsu	Read Replies (1) \| Respond to of 1583406

BC, Pfizer and other Big Pharma companies sit on tons of IP. Much of it doesn't result in new drugs because it's not profitable for them. In the case of mRNA, Pfizer saw no need to bring it to market until the COVID pandemic. They were just fine sticking with traditional vaccines. Only when the need arose for a quick-to-develop vaccine did Pfizer decide to try out mRNA. And even then, Pfizer was just one of ten vaccines being developed for COVID. That's why the 10-year timeline doesn't apply here. Same with Gilead's remdesivir, the first treatment approved by the FDA for COVID. Gilead didn't have to wait 10 years before bringing remdesivir into the market. Tenchusatsu